Michel Sadelain

Presented an overview of CAR T therapy potential in oncology and other fields, including the 1XX signaling module and an HLA-independent T cell receptor developed with CRISPR.

Hamburg Hosts 2026 European Gene Therapy Conference with Focus on Safety and HIV Vaccine Progress